INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 368 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2024. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $259,029 | -53.1% | 3,782 | -64.3% | 0.01% | -64.9% |
| Q3 2023 | $552,258 | +0.8% | 10,602 | +22.5% | 0.04% | +2.8% |
| Q2 2023 | $548,098 | -5.4% | 8,656 | -19.1% | 0.04% | -12.2% |
| Q1 2023 | $579,080 | +952.9% | 10,694 | +799.4% | 0.04% | +925.0% |
| Q3 2022 | $55,000 | -90.9% | 1,189 | -89.7% | 0.00% | -91.8% |
| Q4 2021 | $604,000 | +1625.7% | 11,554 | +730.6% | 0.05% | +1125.0% |
| Q3 2020 | $35,000 | -64.3% | 1,391 | -89.4% | 0.00% | -60.0% |
| Q3 2019 | $98,000 | +1300.0% | 13,174 | +1845.9% | 0.01% | +900.0% |
| Q4 2018 | $7,000 | -93.0% | 677 | -85.3% | 0.00% | -85.7% |
| Q3 2018 | $100,000 | +9900.0% | 4,609 | +5520.7% | 0.01% | – |
| Q2 2018 | $1,000 | -99.2% | 82 | -98.6% | 0.00% | -100.0% |
| Q1 2018 | $119,000 | +133.3% | 5,698 | +61.2% | 0.01% | +100.0% |
| Q4 2017 | $51,000 | -62.2% | 3,534 | -59.0% | 0.01% | -61.5% |
| Q3 2017 | $135,000 | +321.9% | 8,614 | +233.1% | 0.01% | +333.3% |
| Q2 2017 | $32,000 | -44.8% | 2,586 | -33.1% | 0.00% | -50.0% |
| Q4 2016 | $58,000 | +141.7% | 3,864 | +527.3% | 0.01% | +50.0% |
| Q3 2015 | $24,000 | – | 616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 360,000 | $11,502,000 | 2.65% |
| Redmile Group, LLC | 610,171 | $19,495,000 | 1.60% |
| Pier Capital, LLC | 257,256 | $8,219,000 | 1.18% |
| WALL STREET ASSOCIATES | 358,857 | $11,465,000 | 1.08% |
| SENZAR ASSET MANAGEMENT, LLC | 161,300 | $5,154,000 | 0.88% |
| Rhenman & Partners Asset Management AB | 206,000 | $6,582,000 | 0.79% |
| EAM Investors, LLC | 152,389 | $4,869,000 | 0.57% |
| EDMOND DE ROTHSCHILD (SUISSE) S.A. | 50,000 | $1,598,000 | 0.51% |
| Visium Asset Management, LP | 1,051,479 | $33,595,000 | 0.48% |
| SPHERA FUNDS MANAGEMENT LTD. | 128,000 | $4,090,000 | 0.40% |